Background: Ionized magnesium levels are elevated in fetal blood compared with maternal blood, suggesting that the placenta may possess an active transport mechanism for magnesium. In the present study, we sought to determine the existence of an active transport mechanism for magnesium in the placenta using cultured trophoblast cells. Methods: Using choriocarcinoma cells as a model system, we attempted to demonstrate the presence of a functional Na ϩ /Mg 2ϩ exchanger. Human choriocarcinoma JEG-3 cells cultured on glass coverslips were loaded with MAG-Fura 2-AM (5 mol/L ϫ 30 min) to spectrofluorometrically assess kinetics of intracellular magnesium ( 
M
aternal-fetal homeostasis depends on a properly functional placenta, for when the integrity of the placenta is compromised, both mother and fetus experience unwanted complications. Abnormal placentation occurs in preeclampsia. 1 In addition, maternal administration of magnesium sulfate, the current therapeutic agent for preeclampsia, has been shown to be elevated in fetal blood and to have direct effects on heart rate after placental passage. 2, 3 Therapeutic levels of magnesium have also been found to produce specific placental effects such as vasodilation. 4 Magnesium is an important intracellular cation with a variety of functions. Physiologically, magnesium is an essential cofactor in enzymatic function and is involved in cellular energy metabolism. 5 In addition, magnesium is required for proper functioning of the Na ϩ -K ϩ ATPase and also acts as a competitive antagonist of calcium channels. Magnesium also has a structural function in DNA, RNA, and activated amino acids. 6 The physiology of placental magnesium exchange and its control mechanisms remain poorly understood. What has been demonstrated, however, is that the levels of total calcium, ionized calcium, and magnesium are increased in the fetal circulation compared with the maternal. 7 We have found that these maternal-fetal gradients are maintained despite maternal magnesium supplementation in cases of preeclampsia. 8 These data suggest an active transport role for the placenta. The maternal concentration of magnesium, whether hypomagnesemic or hypermagnesemic, appears to influence transport of the ions across the placenta. Although the exact mechanism of placental magnesium transport is unknown, it has been found to be sodium dependent. 9 A Na ϩ -Mg 2ϩ antiporter has been described in human erythrocytes, 10 making it plausible that a similar Na ϩ -Mg 2ϩ exchange may occur in the placenta to account for these ion gradients. In the present study, we used human choriocarcinoma JEG-3 cytotrophoblast cells as a model system to study placental magnesium transport. The JEG-3 cell line has been found to be an excellent cell model to study basic placental function, 11 and produces hCG, hCS, progesterone, and estrogen much like normal trophoblast cells.
12

Methods
Human choriocarcinoma JEG-3 cells were obtained from American Type Culture Collection (Rockville, MD). Cells were cultured in Dulbecco's modified Eagle's minimum essential medium supplemented with 10% fetal bovine serum and streptomycin/penicillin (Gibco BRL, Grand Island, NY) at 37°C, 5% CO 2 and 100% humidity. Cells were subcultured via trypsinization (0.25% trypsin in Ca 2ϩ -free balanced salt solution) and reseeded at a split ratio of 1:3 as described previously for vascular smooth muscle cells. 13 All experiments were performed using cells between passages 2 and 6.
For intracellular free ion measurements, JEG-3 cells were grown to confluence on custom-cut glass coverslips placed in 35-mm culture dishes. On the days of experimentation, cells were incubated in 5 mol/L MAG FURA 2-AM (Molecular Probes, Eugene, OR) for 30 min at 37°C. Coverslips were then inserted diagonally (45 degrees to the incident excitation beam) into a quartz nonfluorescing cuvette and placed in a water-jacketed stage (37°C) in a Spex Fluorolog dual excitation spectrofluorometer (Edison, NJ). After dye loading, cells were superfused via peristaltic pump (approximately 2 mL/min) with prewarmed physiologic saline solution (PSS) containing the following (in mmol/L): 113 NaCl, 4 KCl, 2 MgCl 2 , 1.5 CaCl 2 , 10 HEPES, and 6 glucose, pH 7.4 for 2 to 5 min to remove extracellular dye and to provide additional time for further ester cleavage. For assessment of [Mg 2ϩ ] i , excitation wavelengths were 330 and 370 nm and emission wavelength was 511 nm. For [Ca 2ϩ ] i measurements, wavelengths were 340 nm, 380 nm and 505 nm, respectively. Excitation and emission slits were set at 3 nm. Calibration of intracellular free magnesium levels ([Mg 2ϩ ] i ) was accomplished using subpopulations of JEG-3 cells in representative experiments. Maximal fluorescence (F max ) was obtained with 0.1% Triton X-100/ high MgC1 2 and minimal fluorescence (F min ) was obtained with 10 mmol/L EDTA, pH 8.6. The value of the dissociation constant (K d ) for the Fura:Mg complex was 1.5 mmol/L as reported elsewhere.
14 The relationship of fluorescence ratio units (eg, 330:370) to calibrated [Mg 2ϩ ] i produced a logarithmic function as reported previously.
14 Representative basal [Mg 2ϩ ] i is reported in molar units. To facilitate faster and more convenient throughput in the remaining experiments, changes in cytoplasmic free ion levels are reported in mol/L as determined by a subset of calibrated fluorometric scans correlating fluorescence ratio units to calibrated mol/L [Mg 2ϩ ] i (eg, for magnesium levels: reading at 330 nm divided by reading at 370 nm, both as measured with a 511-nm emission filter).
Interassay equalization of JEG cell seeding densities was ensured by standard hemocytometric methods (ie, standardization using 40,000 cells/mL). Cell viability and adherence were determined in subsets of JEG cells before and immediately after ionic measurements. Representative wells were viewed with phase contrast optics (40 -200ϫ) to determine potential gross areas of cell removal postmeasurement. Additionally, cell viability was validated via trypan blue exclusion, as we have described elsewhere. 15 Extracellular sodium levels were varied by supplementing choline chloride for NaCl in physiologic salt solution (PSS). Extracellular Mg 2ϩ and Ca 2ϩ were varied by addition or subtraction of their respective chloride salts, and osmotic control solutions were prepared with equimolar concentrations of mannitol. The JEG-3 cells were exposed to various combinations of PSS, imipramine (Na , by constant superfusion via a peristaltic pump and a four-way valve located between the pump and sample cuvette.
Quantitative results for basal ion levels, peak ion levels, time-to-peak ion concentrations, and time-to-basal [Mg 2ϩ ] i are given as mean Ϯ SEM. Population means were analyzed via Student paired t test and were considered to be statistically significantly different at values of P Ͻ .05.
Results
Calibrated measurements of basal [Mg 2ϩ ] i in a subset of JEG-3 cells resulted in an average level of 439 Ϯ 44 mol/L (n ϭ 4). Fig. 1A shows a representative fluorometric scan, and Fig. 1B ] i was not dependent upon the presence of extracellular calcium ( Fig. 2A) , but was completely dependent upon extracellular magnesium (Fig. 2B) . Summary data for four experiments each are shown in Fig. 2C .
Because (Fig. 3) . Absent from these experiments were the transient phases induced by sodium lowering as shown in Fig. 1 (Fig. 4) . However, imipramine abolished the return-to-basal phase of the magnesium response elicited by lowering extracellular sodium from 145 mmol/L to 50 mmol/L.
Finally, to determine whether stepwise increases in extracellular magnesium regulates [Mg 2ϩ ] i , the JEG-3 cells were scanned during additions of 1 and 15 mmol/L MgCl 2 to PSS that was originally devoid of magnesium at time 0. Fig. 5 
Discussion
Recent evidence has implicated magnesium deficiency in complications of pregnancy such as preeclampsia, 17 gestational diabetes, 18 and preterm labor. 19 In pregnant women, hypomagnesemia has been found to be more pronounced in women with preeclampsia, a syndrome characterized by hypertension and proteinuria. 17, 20 Hypomagnesemia is associated with increased blood pressure and total peripheral resistance. 21, 22 Resnick et al 23 have found intracellular magnesium to be lower, whereas intracellular calcium is higher in patients with hypertension. Moreover, intracellular magnesium depletion has been found in pregnancy. 24 It is possible that placental shifts of magnesium may relate to the etiology of these disorders or may be a key factor in fetal health and well-being during this time.
Placental regulation of magnesium transport is not well understood. To our knowledge, the present study is the first to investigate magnesium transport in pure populations of cytotrophoblasts. Although it is not completely clear which cell type in the placenta is responsible for magnesium transport and maternal-fetal gradients, our initial studies demonstrate that Na ϩ /Mg 2ϩ exchange is an important homeostatic mechanism in cytotrophoblasts. A Na ϩ -dependent Mg 2ϩ transporter has functionally been demonstrated in many cell types; however, the protein responsible for this has not yet been cloned, nor has this protein been fully characterized. The current study helps to elucidate some of the characteristics of this transporter in the placenta.
Using cultured choriocarcinoma cells, our results demonstrate that human cytotrophoblasts express an imipramine-and sodium-dependent magnesium transport system poised to exchange extracellular sodium for intracellular magnesium. Furthermore, sodium-dependent Mg 2ϩ transport is completely dependent upon extracellular magnesium but is independent of extracellular calcium. Finally, extracellular magnesium levels regulate intracellular levels of this ion.
Cytotrophoblast cells are the precursors to the syncytiotrophoblast cells, which are considered to be the transporting cells between mother and fetus in the human placenta. Cytotrophoblast cells undergo mitosis and thus are suitable for studies in isolated cells. 25 In this study, we used JEG-3 cells, a choriocarcinoma cell line, because these cells have properties (such as peptide and hormone production) that are found in normal trophoblast cells. 12 In addition, because cytotrophoblasts continuously differentiate and fuse so as to enlarge and form multinucleated cells with properties similar to syncytiotrophoblasts, we believe that this model is an appropriate one to study. Furthermore, we avoided potential contamination with other cells and tissues, such as red blood cells, which do transport magnesium. 10 Thus, although these cells are choriocarcinomic, they have many properties of normal placental cells and are a good system to begin to describe placental transport of magnesium.
Most data to date regarding placental regulation of magnesium transport have been acquired using isolated membrane vesicles, villus tissue fragments and in vitro perfusion studies. 9, 18, 26, 27 Very few studies have been done using cultured trophoblast cells. Cultured cytotrophoblasts have been used to examine calcium flux, 28 and these cells have been found to have a calcium-sensing receptor that may play a role in regulating placental calcium transport. 29 Additional studies using the in situ perfused rat placenta have found that calcium transport in the placenta is not affected by maternal hypermagnesemia 26 or by maternal magnesium deficiency. 30 Thus, two separate transporters (one for calcium and one for magnesium) are likely to exist in the placenta.
Mechanisms for cellular magnesium efflux and influx in a variety of cell types include a Na the requirements of the cell. 31 When Mg 2ϩ transport is not coupled to Na ϩ transport, Mg 2ϩ -Mg 2ϩ exchange is likely to occur. 32 In the present study, when extracellular sodium is lowered, intracellular magnesium rises in a fashion predicted by the existence of a Na ϩ /Mg 2ϩ exchanger, 33 but then returns over time to basal levels. The mechanism underlying this decrease is unclear, but may involve imipramine-sensitive: 1) sodium-independent magnesium efflux, 2) cellular buffering of magnesium, or 3) sequestration of the ion into intracellular storage depots (eg, mitochondria). In squid axon and barnacle muscle, Mg 2ϩ efflux was found to have a sodium-independent component. 34 A sodium-independent Mg 2ϩ transport has also been observed in erythrocytes. 10 Whether there is a Na ϩ -independent component of magnesium transport in the placenta remains to be investigated.
Although 27, 36 However, in placental perfusion studies, altering trophoblast pH had no effect on maternalfetal clearance of magnesium. 9 Erythrocytes from hypertensive patients display low intracellular pH associated with lower [Mg 2ϩ ] i . 23 The effects of pH, Na ] i in trophoblast cells. Some degree of fetal magnesium depends on maternal sources as both hyper-and hypomagnesia lead to similar changes in plasma magnesium in offspring. 2, 8, 26 Should a Na ϩ /Mg 2ϩ antiporter be defective in the preeclamptic placenta, it may contribute to the hypomagnesemia and vasoconstriction observed in these patients. Future studies further characterizing a Na ϩ /Mg 2ϩ antiporter in isolated term trophoblast cells are warranted. 
